260 related articles for article (PubMed ID: 28448194)
21. COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways.
Liang XH; Sun H; Nichols JG; Allen N; Wang S; Vickers TA; Shen W; Hsu CW; Crooke ST
Nucleic Acids Res; 2018 Nov; 46(19):10225-10245. PubMed ID: 30239896
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice.
Shemesh CS; Yu RZ; Gaus HJ; Seth PP; Swayze EE; Bennett FC; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Aug; 26(4):223-35. PubMed ID: 27031383
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice.
Yu RZ; Zhang H; Geary RS; Graham M; Masarjian L; Lemonidis K; Crooke R; Dean NM; Levin AA
J Pharmacol Exp Ther; 2001 Feb; 296(2):388-95. PubMed ID: 11160622
[TBL] [Abstract][Full Text] [Related]
24. Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes.
Liang XH; Sun H; Hsu CW; Nichols JG; Vickers TA; De Hoyos CL; Crooke ST
Nucleic Acids Res; 2020 Feb; 48(3):1372-1391. PubMed ID: 31840180
[TBL] [Abstract][Full Text] [Related]
25. Hsc70 Facilitates Mannose-6-Phosphate Receptor-Mediated Intracellular Trafficking and Enhances Endosomal Release of Phosphorothioate-Modified Antisense Oligonucleotides.
Liang XH; Nichols JG; Hsu CW; Crooke ST
Nucleic Acid Ther; 2021 Aug; 31(4):284-297. PubMed ID: 33567234
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice.
Prakash TP; Yu J; Kinberger GA; Low A; Jackson M; Rigo F; Swayze EE; Seth PP
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3774-3779. PubMed ID: 30342955
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Kim Y; Jo M; Schmidt J; Luo X; Prakash TP; Zhou T; Klein S; Xiao X; Post N; Yin Z; MacLeod AR
Mol Ther; 2019 Sep; 27(9):1547-1557. PubMed ID: 31303442
[TBL] [Abstract][Full Text] [Related]
28. High-resolution visualization and quantification of nucleic acid-based therapeutics in cells and tissues using Nanoscale secondary ion mass spectrometry (NanoSIMS).
He C; Migawa MT; Chen K; Weston TA; Tanowitz M; Song W; Guagliardo P; Iyer KS; Bennett CF; Fong LG; Seth PP; Young SG; Jiang H
Nucleic Acids Res; 2021 Jan; 49(1):1-14. PubMed ID: 33275144
[TBL] [Abstract][Full Text] [Related]
29. Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.
Moschos SA; Frick M; Taylor B; Turnpenny P; Graves H; Spink KG; Brady K; Lamb D; Collins D; Rockel TD; Weber M; Lazari O; Perez-Tosar L; Fancy SA; Lapthorn C; Green MX; Evans S; Selby M; Jones G; Jones L; Kearney S; Mechiche H; Gikunju D; Subramanian R; Uhlmann E; Jurk M; Vollmer J; Ciaramella G; Yeadon M
Mol Ther; 2011 Dec; 19(12):2163-8. PubMed ID: 21971426
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis.
Pandey E; Harris EN
Mol Ther Nucleic Acids; 2023 Sep; 33():430-443. PubMed ID: 37575283
[TBL] [Abstract][Full Text] [Related]
31. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.
Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL
Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437
[TBL] [Abstract][Full Text] [Related]
32. Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides.
Wang S; Sun H; Tanowitz M; Liang XH; Crooke ST
Nucleic Acids Res; 2016 Sep; 44(15):7314-30. PubMed ID: 27378781
[TBL] [Abstract][Full Text] [Related]
33. Phospholamban Inhibition by a Single Dose of Locked Nucleic Acid Antisense Oligonucleotide Improves Cardiac Contractility in Pressure Overload-Induced Systolic Dysfunction in Mice.
Morihara H; Yamamoto T; Oiwa H; Tonegawa K; Tsuchiyama D; Kawakatsu I; Obana M; Maeda M; Mohri T; Obika S; Fujio Y; Nakayama H
J Cardiovasc Pharmacol Ther; 2017 May; 22(3):273-282. PubMed ID: 27811197
[TBL] [Abstract][Full Text] [Related]
34. Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines.
Linnane E; Davey P; Zhang P; Puri S; Edbrooke M; Chiarparin E; Revenko AS; Macleod AR; Norman JC; Ross SJ
Nucleic Acids Res; 2019 May; 47(9):4375-4392. PubMed ID: 30927008
[TBL] [Abstract][Full Text] [Related]
35. Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly.
Wang Y; Shen W; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Dec; 29(6):343-358. PubMed ID: 31429620
[TBL] [Abstract][Full Text] [Related]
36. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells.
Liang XH; Shen W; Sun H; Prakash TP; Crooke ST
Nucleic Acids Res; 2014 Jul; 42(12):7819-32. PubMed ID: 24861627
[TBL] [Abstract][Full Text] [Related]
37. Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells.
Wang S; Allen N; Prakash TP; Liang XH; Crooke ST
Nucleic Acid Ther; 2019 Oct; 29(5):245-255. PubMed ID: 31158063
[TBL] [Abstract][Full Text] [Related]
38. Gene Silencing Activity and Hepatic Accumulation of Antisense Oligonucleotides Bearing Cholesterol-Conjugated Thiono Triester at the Gap Region.
Nakajima M; Kasuya T; Yokota S; Onishi R; Ikehara T; Kugimiya A; Watanabe A
Nucleic Acid Ther; 2017 Aug; 27(4):232-237. PubMed ID: 28418770
[TBL] [Abstract][Full Text] [Related]
39. Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs.
Liang XH; Nichols JG; De Hoyos CL; Sun H; Zhang L; Crooke ST
Nucleic Acids Res; 2021 Aug; 49(14):8277-8293. PubMed ID: 34244781
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the Activity and Distribution of a 2'-O-Methoxyethyl-Modified Antisense Oligonucleotide in Models of Acute and Chronic Kidney Disease.
Donner AJ; Bell TA; Greenlee S; Graham MJ; Crooke RM
Nucleic Acid Ther; 2018 Oct; 28(5):297-306. PubMed ID: 30133341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
